Due to the unprecedented nature of the COVID-19 pandemic, anyone reporting an Adverse Event and/or a Product Complaint via phone, should you receive a network busy signal (ie: if all lines busy/engaged) please continue to try your call throughout the day. Alternatively, you may email your Adverse Event to drugsafety@propharmagroup.com OR Product Complaint to productcomplaint@propharmagroup.com, OR medical information request to MedInfo@propharmagroup.com.

CISplatin for Injection, USP

Therapeutic Category: Oncology

IT’S BACK AS A STERILE POWDER

  • 50 mg Sterile Powder
  • Preservative Free
  • Does Not Contain Natural Rubber Latex
  • Bar Coded

To order WGCC products, please contact your wholesaler or call Customer Service at 1-888-493-0861.


NDC # Total Amount Fill Volume Container Type Closure Pack Size Package Insert Barcodes
44567-530-01 50 mg n/a 100 mL Vial 20 mm 1 Vial Carton

WARNING: NEPHROTOXICITY, PERIPHERAL NEUROPATHY, NAUSEA AND VOMITING, and MYELOSUPPRESSION
See full prescribing information for complete boxed warning.

  • Nephrotoxicity: cisplatin for injection can cause severe renal toxicity, including acute renal failure. Ensure adequate hydration. Consider dose reductions or alternative treatments in patients with renal impairment.
  • Peripheral Neuropathy: cisplatin for injection can cause dose-related peripheral neuropathy.
  • Nausea and Vomiting: cisplatin for injection can cause severe nausea and vomiting. Premedicate with antiemetics.
  • Myelosuppression: cisplatin for injection can cause severe myelosuppression with fatalities due to infections. Monitor blood counts and interrupt therapy accordingly.

WG Critical Care Product Catalog

To order WGCC products, please contact your wholesaler or call Customer Service at 1-888-493-0861.
© 2020 WG Critical Care, LLC | A PharmaSphere Company | 120 Rte 17 N, Paramus, NJ 07652